A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR.
Han S, Tushoski-Alemán GW, Zhang P, Zheng G, Zhou D, Huo Z, Licht J, George TJ, Allegra C, Trevino JG, Hughes SJ.
Han S, et al. Among authors: zheng g.
Neoplasia. 2024 Nov 13;59:101070. doi: 10.1016/j.neo.2024.101070. Online ahead of print.
Neoplasia. 2024.
PMID: 39541736
Free article.